Related by context. All words. (Click for frequent words.) 79 OPAXIO 66 Hycamtin 65 pixantrone 65 Xyotax 65 Amrubicin 64 FTY# 64 Fludara 63 amrubicin 63 TEMODAL 63 Allovectin 7 ® 63 Taxotere ® 63 Nexavar ® 63 picoplatin 63 panitumumab 62 BAY #-# 62 XYOTAX TM 62 TRISENOX ® 62 obatoclax 62 ixabepilone 62 Tavocept 62 pralatrexate 62 TRISENOX R 62 ganetespib 62 vinorelbine 62 Targretin 62 ASA# 62 Gliadel Wafer 62 Vectibix 62 talactoferrin 62 forodesine 62 TELCYTA 62 EOquin 61 AEG# 61 tesmilifene 61 Ceplene 61 ridaforolimus 61 YERVOY 61 Velcade bortezomib 61 oral ridaforolimus 61 TRISENOX 61 valopicitabine 61 BEXXAR 61 Xanafide 61 Insegia 61 clofarabine 61 Pemetrexed 61 sorafenib 61 axitinib 61 TREANDA 61 Torisel 61 Junovan 60 satraplatin 60 INC# 60 EGFR inhibitors 60 INTEGRILIN 60 Onrigin 60 Vidaza 60 Ixempra 60 relapsed SCLC 60 neratinib 60 Bortezomib 60 ADVEXIN 60 Marqibo 60 sunitinib malate 60 perifosine 60 sapacitabine 60 cetuximab Erbitux 60 VIDAZA 60 bendamustine 60 AP# [003] 60 ularitide 60 Tarceva TM 60 enzastaurin 60 Herceptin trastuzumab 60 IRESSA 59 Clolar 59 alvespimycin 59 pitavastatin 59 bevacizumab Avastin 59 HuLuc# 59 bazedoxifene 59 gefitinib 59 Abraxane 59 Sandostatin LAR 59 Virulizin R 59 vandetanib 59 thymalfasin 59 IL# PE#QQR 59 5-FU/LV 59 unresectable stage 59 Vandetanib 59 Tamibarotene 59 Seliciclib 59 FOLOTYN 59 romiplostim 59 Ceflatonin 59 CoFactor 59 TELINTRA 59 MyVax R 59 sorafenib Nexavar 59 abiraterone acetate 59 Erlotinib 59 Cloretazine R VNP#M 59 fluoropyrimidine 59 Avastin bevacizumab 59 DOXIL 59 Mylotarg 59 refractory Hodgkin lymphoma 59 goserelin 59 orBec R 59 metastatic HRPC 59 decitabine 59 Bezielle 59 HuMax CD4 59 darapladib 59 durable remissions 59 glufosfamide 59 posaconazole 59 Taxotere R 59 SIR Spheres 59 OvaRex ® MAb 59 #D#C# 59 MGCD# [001] 59 Proxinium TM 59 Allovectin 7 R 58 Amigal 58 PRT# 58 YONDELIS 58 tamibarotene 58 PXD# 58 cilengitide 58 Tarvacin 58 Zerenex 58 recurrent NSCLC 58 Specifid 58 Asentar 58 teriflunomide 58 lintuzumab 58 PROMACTA 58 Hycamtin ® 58 HuMax EGFr 58 Nexavar sorafenib 58 cintredekin besudotox 58 depsipeptide 58 taxane 58 oral anticoagulant 58 MAGE A3 ASCI 58 pirfenidone 58 TOCOSOL Paclitaxel 58 BrachySil 58 Gemzar ® 58 pertuzumab 58 Icatibant 58 PEG INTRON 58 COPEGUS 58 VEGF Trap 58 regorafenib 58 refractory multiple myeloma 58 non squamous NSCLC 58 squamous histology 58 Cloretazine ® 58 Dacogen injection 58 ELACYT 58 Taxotere docetaxel 58 KNS # 58 ABRAXANE 58 MOZOBIL 58 Trastuzumab 58 EFAPROXYN 58 docetaxel Taxotere ® 58 TTF Therapy 58 teduglutide 58 febuxostat 58 calcineurin inhibitors 58 DU #b 58 Navelbine ® 58 celgosivir 58 pegfilgrastim 58 telbivudine 58 NUEDEXTA 58 UPLYSO 58 Camptosar ® 58 cetuximab 58 Civacir 58 trabectedin 58 HuMax CD# 58 ruxolitinib 58 alvimopan 58 Viramidine 58 gemcitabine cisplatin 58 radiation sensitizer 58 ACZ# 58 imatinib Gleevec 58 lapatinib Tykerb 58 Bronchitol 58 romidepsin 58 oral FTY# 58 HER2 positive metastatic breast 58 cisplatin chemotherapy 58 docetaxel Taxotere R 58 ambrisentan 58 MEPACT 58 tezampanel 58 eltrombopag 58 rNAPc2 58 carvedilol 58 Tarceva erlotinib 58 HGS ETR1 58 mycophenolate mofetil 58 INTEGRILIN ® 58 Jevtana 58 CAELYX 58 Azedra 57 MoxDuo IR 57 Troxatyl 57 Advexin 57 temsirolimus 57 Reverset 57 sunitinib 57 Campath ® 57 tanespimycin 57 platelet inhibitor 57 pain palliation 57 VPRIV 57 Removab 57 anticancer compound 57 CR# vcMMAE 57 neoadjuvant therapy 57 UVIDEM 57 locoregional 57 Genasense ® 57 docetaxel 57 gemcitabine carboplatin 57 INCB# [002] 57 proteasome inhibitor 57 Xinlay 57 elotuzumab 57 TORISEL 57 Debio 57 terlipressin 57 Virulizin ® 57 CA4P 57 advanced NSCLC 57 clodronate 57 SinuNase 57 Treanda 57 carfilzomib 57 custirsen 57 seliciclib 57 Eribulin 57 TYZEKA 57 Intravenous CP 57 sorafenib tablets 57 aflibercept 57 Raptiva ® 57 Bevacizumab 57 Genasense 57 metastatic renal cell carcinoma 57 daclizumab 57 octreotide LAR 57 refractory PTCL 57 dacarbazine chemotherapy 57 infusional 5-FU/LV 57 CIMZIA ™ 57 HoFH 57 T DM1 57 EndoTAG TM -1 57 SERMs 57 surrogate endpoint 57 registrational trial 57 Doxil ® 57 Tyrima 57 ponatinib 57 L BLP# 57 plus dexamethasone 57 anidulafungin 57 efaproxiral 57 relapsed ovarian cancer 57 Cloretazine 57 hypomethylating agents 57 MEK inhibitors 57 Azilect ® 57 Onbrez Breezhaler 57 TAXOTERE ® 57 Azixa 57 Phenoptin 57 pemetrexed 57 Allovectin 7 57 vicriviroc 57 Clolar ® 57 pegylated liposomal doxorubicin 57 voreloxin 57 iniparib 57 Numax 57 aleglitazar 57 oral rivaroxaban 57 pomalidomide 57 CD# antibody [001] 57 Taxotere 57 Paraplatin ® 57 trastuzumab Herceptin 57 RAPAFLO 57 ISENTRESS 57 cytotoxic chemotherapy 57 zoledronic acid 57 BCIRG 57 phase IIb clinical 57 PEG SN# 57 standard chemotherapy regimen 57 MYDICAR ® 57 brentuximab vedotin 57 LY# [003] 57 interferon alfa 57 vidofludimus 57 FOLFIRINOX 57 Evoltra 57 docetaxel chemotherapy 57 Doxil 57 INCB# [001] 57 Arixtra 57 doxorubicin 57 gemcitabine chemotherapy 57 oral prodrug 57 Vidofludimus 57 PROSTVAC TM 57 Pirfenidone 57 Traficet EN 57 estramustine 57 dasatinib 57 metastatic castration resistant 56 palonosetron 56 omacetaxine 56 erlotinib Tarceva 56 nab paclitaxel 56 Phase 2a trial 56 platinum refractory 56 taliglucerase alfa 56 Cellegesic 56 cediranib 56 Dacogen 56 GVAX 56 Onsolis 56 protease inhibitor PI 56 SILENOR TM 56 NOXAFIL 56 recurrent glioblastoma multiforme 56 Symadex 56 vemurafenib 56 refractory chronic lymphocytic 56 Gefitinib 56 cutaneous T cell 56 Perifosine 56 bevacizumab 56 carboplatin paclitaxel 56 cytotoxic therapy 56 tafamidis 56 fluvastatin 56 Panzem R NCD 56 MyVax 56 NEBIDO 56 oxaliplatin 56 Pixantrone 56 metastatic hormone refractory 56 Temsirolimus 56 pediatric acute lymphoblastic 56 Increlex R 56 Dasatinib 56 BENLYSTA ® 56 Neurodex 56 PI3K/Akt pathway inhibitor 56 Rasilez Tekturna 56 palifosfamide 56 Leukine 56 topotecan 56 LEUKINE 56 CBLC# 56 zalutumumab 56 Campath 56 Mepact 56 chemotherapeutic agent 56 lasofoxifene 56 Nexavar 56 silodosin 56 ZYBRESTAT 56 erlotinib Tarceva ® 56 huC# DM4 56 Combidex 56 paclitaxel Taxol 56 brivaracetam 56 paclitaxel Taxol ® 56 Cytoxan 56 ONCONASE 56 elagolix 56 recurrent ovarian cancer 56 relapsed refractory multiple myeloma 56 mifamurtide 56 cetuximab Erbitux ® 56 PROCHYMAL 56 REVLIMID lenalidomide 56 dirucotide 56 Telcyta 56 RAD# [003] 56 refractory indolent non 56 lenalidomide 56 PrevOnco 56 Alpharadin 56 metastatic castrate resistant 56 GRNVAC1 56 Evoltra TM 56 Glufosfamide 56 figitumumab 56 mCRC patients 56 Cimzia TM 56 EGFR mutation 56 Phase #/#a trial 56 LUX Lung 56 Halaven 56 ALN RSV# 56 oxymorphone ER 56 Gleevec Glivec 56 Zytiga 56 pan HDAC inhibitor 56 Peg IFN 56 velafermin 56 Atrasentan 56 Ozarelix 56 Alemtuzumab 56 methylnaltrexone 56 anticancer therapies 56 paclitaxel carboplatin 56 Camptosar 56 letrozole Femara 56 eniluracil 56 Vidaza azacitidine 56 Fibrillex TM 56 Letairis 56 L MTP PE 56 mRCC 56 temozolomide 56 BLP# Liposome Vaccine 56 micafungin 56 RhuDex ® 56 mapatumumab 56 Cloretazine R 56 volociximab 56 cabazitaxel 56 Elagolix 56 Lenalidomide 56 QuadraSphere 56 dasatinib Sprycel 56 systemic ALCL 56 Gleevec imatinib 56 pediatric malignancies 56 NSCLC 56 vismodegib 56 PTK ZK 56 anticancer therapy 56 LHRH antagonist 56 Maraviroc 56 taxanes 56 trastuzumab Herceptin ® 56 intravenous bisphosphonates 56 SUTENT 56 pegloticase 56 Exemestane 56 imatinib mesylate 56 Oxaliplatin 56 Cimzia ® certolizumab pegol 56 VAPRISOL 56 AZILECT ® 56 ZEVALIN 56 ISTODAX 55 ZACTIMA 55 low dose cytarabine 55 rilpivirine 55 EOquin TM 55 Satraplatin 55 sipuleucel T 55 mertansine 55 XmAb# 55 XL# [003] 55 anti leukemic 55 IMA# 55 OncoVEX GM CSF 55 degarelix 55 ONTAK 55 Voreloxin 55 LymphoStat B 55 vorinostat 55 BRIM2 55 ELND# 55 Pralatrexate 55 CIMZIA TM 55 Rituxan rituximab 55 LymphoStat B belimumab 55 OHR/AVR# 55 octreotide 55 biologic therapy 55 Irinotecan 55 Syncria 55 rhThrombin 55 OXi# 55 ticagrelor 55 plus gemcitabine 55 ocrelizumab 55 acute promyelocytic leukemia APL 55 Epirubicin 55 Everolimus 55 Gleevec resistant 55 PegIntron 55 Panzem R 55 castration resistant prostate cancer 55 REMICADE ® 55 Pfizer Sutent 55 relapsed myeloma 55 GV# [001] 55 OncoVEX 55 AVASTIN 55 MAA submission 55 refractory AML 55 Promacta 55 AZOR 55 systemically administered 55 TYKERB 55 ABRAXANE ® 55 Carfilzomib 55 brentuximab vedotin SGN 55 trastuzumab DM1 55 Zevalin 55 Paclitaxel 55 veltuzumab 55 GATTEX 55 Cinryze TM 55 Increlex ® 55 CCX# 55 Tykerb 55 INTELENCE 55 HQK 55 azacitidine 55 humanized anti 55 PROSTVAC ® 55 pancreatic neuroendocrine tumors 55 elesclomol 55 Ceplene/IL-2 55 Votrient 55 REOLYSIN ® 55 Plicera 55 Vectibix panitumumab 55 metastatic CRC 55 Aviptadil 55 hormone refractory metastatic prostate 55 otelixizumab 55 ProLindac 55 BYDUREON 55 bosentan 55 convenient dosing regimens 55 pradefovir 55 abiraterone 55 fostamatinib 55 MabCampath 55 MYDICAR 55 generation purine nucleoside 55 RSR# 55 chlorambucil 55 CINTREDEKIN BESUDOTOX 55 bucindolol 55 XELOX 55 xanthine oxidase inhibitor 55 Vimpat ® lacosamide 55 Tanespimycin 55 AEZS 55 pazopanib 55 dacarbazine 55 tocilizumab 55 Hepatocellular Carcinoma HCC 55 Amgen Vectibix 55 Revlimid 55 ZOLINZA 55 tolevamer 55 AZILECT R 55 Sorafenib 55 luteinizing hormone releasing 55 TroVax ® 55 LEP ETU 55 Prestara 55 PREZISTA r 55 pegylated interferons 55 nucleoside analogue 55 Actemra 55 chemotherapeutic regimen 55 gemcitabine 55 ibandronate 55 Octreolin 55 Degarelix 55 chronic angina 55 Leukine ® 55 Omacetaxine 55 liposomal formulation 55 nilotinib 55 lumiliximab 55 orBec 55 Copegus ribavirin 55 darunavir 55 Alocrest 55 CTAP# Capsules 55 Emselex 55 gefitinib Iressa 55 DCVax R Brain 55 sBLA 55 FOLFIRI 55 OMNARIS HFA 55 Panzem 55 alkylating agents 55 peg IFN 55 elacytarabine 55 Zolinza 55 Stimuvax R 55 TNFerade 55 Peginterferon alfa 2b 55 bortezomib 55 alemtuzumab 55 somatostatin analogues 55 Cotara 55 R sorafenib tablets 55 neoadjuvant 55 OMAPRO 55 Cethrin 55 atrasentan 55 NKTR 55 Aromasin 55 rindopepimut 55 CMV disease 55 FOLFOX4 55 PSMA ADC 55 TNF inhibitors 55 adecatumumab 55 talabostat 55 metastatic GIST 55 remission induction 55 cinacalcet HCl 55 PRTX 55 ADVEXIN therapy 55 ALGRX 55 Thalomid ® 55 Synvisc One 55 interferon alfa 2b 55 Ridaforolimus 55 Silodosin 55 entinostat 55 liver metastases 55 Taxotere chemotherapy 55 BEMA TM Fentanyl 55 anticancer agent 55 telaprevir 55 B CLL 55 PEG Interferon lambda 55 Teysuno 55 bevacizumab Avastin ® 55 incyclinide 55 Mipomersen 55 anti angiogenic agents 55 atacicept 55 proteasome inhibitors 54 deforolimus 54 Canvaxin 54 chronic HCV 54 trastuzumab DM1 T DM1 54 gemcitabine Gemzar 54 paclitaxel poliglumex 54 anastrozole 54 Azixa ™ 54 Quinamed 54 canakinumab 54 afatinib 54 Ceflatonin R 54 Triolex 54 Zactima 54 Aurora kinase 54 Advaxis Phase 54 metaglidasen 54 VELCADE 54 dose escalation Phase 54 Stimuvax 54 Pegintron 54 fenofibrate 54 Ophena TM 54 QVA# 54 hormone refractory prostate cancer 54 imatinib mesylate Gleevec 54 Soliris TM eculizumab 54 paclitaxel Taxol R 54 metastatic lung cancer 54 BRAF V# mutation 54 Privigen 54 heavily pretreated 54 androgen independent 54 KRN# 54 FASLODEX 54 COMFORT II 54 Sym# 54 imatinib Gleevec ® 54 Panitumumab 54 Pertuzumab 54 paclitaxel 54 Clevudine 54 G CSF 54 vascular disrupting agent 54 DCVax ® 54 adriamycin 54 Zelrix 54 oral talactoferrin 54 Vicinium TM 54 riociguat 54 efalizumab 54 Tocosol Paclitaxel 54 successfully commercialize Iluvien 54 subcutaneous formulation 54 melphalan prednisone 54 FIRMAGON 54 Celgene Revlimid 54 bortezomib Velcade R 54 TNF antagonists 54 interferon therapy 54 ELOXATIN 54 sargramostim 54 CANCIDAS 54 non squamous 54 lapatinib 54 Exforge 54 corticosteroid dexamethasone 54 denosumab 54 ARIXTRA 54 Evoltra ® 54 receptor tyrosine kinase inhibitor 54 chemoradiotherapy 54 refractory metastatic 54 toremifene 54 PREOS 54 ustekinumab 54 5FU 54 Afinitor 54 gastrointestinal stromal tumors GIST 54 apaziquone 54 refractory CTCL 54 CD3 monoclonal antibody 54 bone metastases 54 PROVENGE 54 docetaxel Taxotere 54 Neulasta ® 54 Mycamine 54 insulin sensitizing 54 Daclizumab 54 sorafenib Nexavar ® 54 YONDELIS R 54 Xeloda ® 54 Actemra tocilizumab 54 Hepsera 54 INT# [002] 54 Tezampanel 54 TNF alpha inhibitor 54 Apaziquone 54 allogeneic stem cell 54 postoperative chemotherapy 54 Tarceva 54 cinacalcet 54 favorable pharmacokinetic profile 54 Erbitux cetuximab 54 MabThera Rituxan 54 ToGA 54 Topotecan 54 telaprevir VX 54 TNF inhibitor 54 SIMPONI 54 REYATAZ R 54 tolerability profiles 54 prostate cancer CRPC 54 BCR ABL inhibitors 54 HGS ETR2 54 Combination therapy 54 palliative radiotherapy 54 ISIS # 54 HspE7 54 tipranavir 54 Aclasta 54 adjuvant chemotherapy 54 HCV protease inhibitor 54 APPRAISE 54 Xcytrin 54 cutaneous T 54 AVOREN 54 IMGN# 54 oritavancin 54 APTIVUS 54 Mitoxantrone 54 elvucitabine 54 Dalbavancin 54 ORENCIA ® 54 MAXY G# 54 XGEVA 54 refractory CLL 54 farletuzumab 54 Adjuvant chemotherapy 54 metastatic gastric 54 adalimumab 54 Telaprevir 54 panitumumab Vectibix 54 Novartis Zometa 54 Keppra ® 54 Elitek 54 peginterferon alfa 54 Revlimid lenalidomide 54 everolimus 54 EGFr 54 aflibercept VEGF Trap 54 recurrent metastatic 54 CAPHOSOL 54 Orphan Drug designations 54 Carboplatin 54 PEG Intron 54 Nimotuzumab 54 resectable 54 ZEGERID Capsules 54 REVLIMID R 54 evaluating tivozanib 54 NGX# 54 adjuvant radiation 54 novel VDA molecule 54 GW# [003] 54 AVN# [001] 54 metastatic RCC 54 SPRYCEL 54 Pazopanib 54 Tracleer R 54 IMiDs 54 chemoradiation 54 ospemifene 54 ofatumumab 54 Eliquis 54 CCR5 receptor antagonist 54 bardoxolone 54 SANCTURA R 54 elinogrel 54 palifermin 54 viral kinetic 54 dacetuzumab 54 bortezomib Velcade 54 anti angiogenic agent 54 lesinurad 54 relapsing MS 54 malignant pleural mesothelioma 54 lupus nephritis 54 nimotuzumab 54 Relivar 54 mg kg dose 54 registrational 54 octreotide acetate 54 AMN# [001] 54 ARIMIDEX 54 ASONEP 54 KRAS mutations 54 dabigatran etexilate 54 velaglucerase alfa 54 Arranon 54 sodium glucose cotransporter 54 Vaprisol 54 aromatase inhibitor 54 Fodosine 54 entecavir 54 IFN beta 54 OMNARIS Nasal Spray 54 Natalizumab 54 Fludara ® 54 dose cohort 54 Peginterferon 54 Certican 54 HRPC 54 Elotuzumab 54 fenofibric acid 54 ONCASPAR 54 Clofarabine 54 certolizumab 54 amphotericin B 54 Zometa zoledronic acid 54 Eltrombopag 54 orally bioavailable 54 PNP inhibitor 54 Aptivus 54 myelodysplastic syndromes MDS 54 ongoing Phase 1b 54 REVLIMID ® 54 leucovorin 54 Erbitux 54 MDV# 54 TAXOTERE R 54 olaparib 54 intravitreal injection 54 antiangiogenic therapy 54 PhosLo 54 anthracycline containing 54 mitomycin 54 TBC# 54 Loramyc R 54 EGFR TKI 54 SCCHN 54 Ventavis 54 JANUVIA 54 rFVIIa 54 epratuzumab 54 BrachySil TM 54 uric acid lowering 54 Loramyc ® 54 oblimersen 54 Targretin capsules 54 T#I [002] 53 Dendreon Provenge 53 Vorinostat 53 KRAS mutations occur 53 Orphan Drug status 53 eprotirome 53 DCVax R 53 Romidepsin 53 TroVax 53 Proquin XR 53 Vectibix monotherapy 53 Menerba 53 Exelixis compounds 53 Abiraterone acetate 53 nucleoside 53 dasatinib Sprycel ® 53 bicalutamide 53 PLX# 53 recurrent GBM patients 53 nonsmall cell lung cancer 53 cancer mCRC 53 Neuradiab 53 tivozanib 53 endocrine therapy 53 golimumab 53 HER2 positive cancers 53 Sandostatin LAR Depot 53 QNEXA 53 Dapagliflozin 53 metastatic colorectal cancer 53 NATRECOR R 53 Yondelis 53 chemotherapeutic drug 53 SCIg 53 registrational studies 53 squalamine 53 ROTATEQ 53 Folotyn 53 CDP# 53 Cinryze ™ 53 TH# [003] 53 alfa 2a 53 zileuton 53 Omnitarg 53 oral diclofenac 53 GSK# [001] 53 Desmoteplase 53 invasive candidiasis 53 Eloxatin ® 53 PRADAXA 53 SVR# 53 TMC# [002] 53 carboplatin 53 complete cytogenetic response 53 HGS# 53 CHOP chemotherapy 53 Vilazodone 53 concurrent chemoradiation 53 biologic therapies 53 caspofungin 53 mcg dose 53 biologic DMARD 53 Epoetin alfa 53 oxaliplatin Eloxatin 53 brain metastases 53 adjuvant therapy 53 refractory acute myeloid 53 granisetron 53 Octreotide 53 Tasigna 53 lubiprostone 53 Bicifadine 53 forodesine HCl 53 eribulin 53 PARP inhibitor 53 advanced hepatocellular carcinoma 53 TASKi3 53 ORENCIA R 53 cytarabine 53 Phase IIIb clinical 53 VEGF inhibitor 53 Corlux 53 NNRTIs 53 antithrombotic 53 RG# [001] 53 AEGR